State
73,817 recalls have nationwide distribution and so reach US Virgin Islands. 178 additional recalls listed US Virgin Islands specifically in their distribution scope.
Of the 178 recalls naming US Virgin Islands we have scored against our rubric, 12 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 39 (22%) are Severe.
Which agencies issued them
These figures cover only the 178 recalls whose distribution notice names US Virgin Islands specifically. The 73,817 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Krud Kutter is recalling about 85,000 adhesive removers because the packaging is not child-resistant and the labels lack required hazard warnings.
Zimmer GmbH is recalling 57,603 units of Natural Nail CM Long intramedullary fixation rods because compromised outer trays may lead to periprosthetic infection.
DJO, LLC is recalling Monode Shortwave Accessories due to overheating and burning of the wire insulation inside the applicator.
Jayco is recalling 2016 Eagle Half Ton fifth wheel trailers because they lack required warning labels on the towing hitch regarding weight limits and braking.
Clinical Innovations, LLC is voluntarily recalling the Ebb Complete Tamponade System due to a potential balloon leak that may prevent the device from delivering therapy when needed.
Ohm Laboratories is recalling Equaline loratadine tablets because they failed potency testing. Consumers should stop using the product and return it to the pharmacy.
Ohm Laboratories is recalling specific lots of loratadine tablets because they failed potency testing. Consumers should stop using the affected medication.
The Mentholatum Company is recalling WellPatch Capsaicin Pain Relief Patches because the word 'not' was missing from safety instructions, potentially leading to improper use.
Ohm Laboratories is recalling Good Neighbor Pharmacy Loratadine Orally Disintegrating Tablets because they failed potency testing.
Ohm Laboratories is recalling specific batches of loratadine orally disintegrating tablets because they failed potency testing. Consumers should stop using the affected products.
Ohm Laboratories is recalling 311 boxes of Allergy Relief (Loratadine) tablets due to an out-of-specification assay result.
Arrow International Inc is recalling 4FR Single Lumen Pressure Injectable PICC catheters because the instructions state they withstand 10 pressure injections, but they are only tested for 5.
Ohm Laboratories is recalling Meijer Loratadine Orally Disintegrating Tablets due to an out-of-specification assay result.
Ohm Laboratories is recalling QC Quality Choice Loratadine Orally Disintegrating Tablets due to an out-of-specification assay result.
Synthes (USA) Products LLC is recalling 793 units of the Screw Inserter because the etched graphics may not correspond to the instrument's actual angle.
Boehringer Ingelheim Roxane Inc. is recalling 5,160 bottles of Furosemide Tablets USP because the wrong active ingredient was used during manufacturing.
Ohm Laboratories is recalling specific batches of Leader Loratadine Orally Disintegrating Tablets because they failed potency testing. Consumers should stop using the affected products.
Ohm Laboratories is recalling Up&Up loratadine tablets because they failed an assay test, potentially making them superpotent.
Alere San Diego is recalling Cholestech LDX Multianalyte Controls because the assigned control ranges for Total Cholesterol and Triglycerides are incorrect.
Ohm Laboratories is recalling Premier Value Loratadine Orally Disintegrating Tablets because an assay test result was out of specification.
Natus Neurology is recalling NicoletOne Software v5.94 because a persistent impedance check signal obscures EEG data, potentially affecting clinical monitoring.
Ohm Laboratories is recalling HEB Loratadine Orally Disintegrating Tablets because an out-of-specification assay result indicated the drug was superpotent.
Boehringer Ingelheim Roxane Inc. is recalling furosemide tablets USP because the wrong active pharmaceutical ingredient was used during manufacturing.
Actavis is recalling 13,284 bottles of Metformin Hydrochloride Extended-Release Tablets, 1000 mg, because they failed dissolution specifications at the 8-hour timepoint.
Ferring Pharmaceuticals is recalling 32,341 vials of Bravelle 75 IU because the drug was found to be subpotent. The recall is voluntary and nationwide.